Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Grabner Gernot |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Amor, M; Diaz, M; Bianco, V; Svecla, M; Schwarz, B; Rainer, S; Pirchheim, A; Schooltink, L; Mukherjee, S; Grabner, GF; Beretta, G; Lamina, C; Norata, GD; Hackl, H; Kratky, D
Proteomic profiling revealed networks between brown adipose tissue and liver in a cardiometabolic mouse model during cold exposure
31st Annual Meeting of the Austrian Atherosclerosis Society (AAS); MAY 2-4, 2024; St. Gilgen, Austria. 2024.
[Oral Communication]
Breithofer, J; Bulfon, D; Fawzy, N; Taschler, U; Grabner, GF; Pirchheim, A; Hartig, L; Hackl, H; Lass, A; Kratky, D; Zimmermann, R
Phospholipase A2 group IVD mediates the transacylation of acylglycerols and glycerophospholipids
9th International Symposium on Lipids and Membrane Biology; April, 18-20; Graz. 2024.
[Oral Communication]
Bulfon, D; Breithofer, J; Grabner, GF; Fawzy, N; Pirchheim, A; Wolinski, H; Kolb, D; Hartig, L; Bramerdorfer, G; Lass, A; Taschler, U; Kratky, D; Greimel, P; Zimmermann, R
The endolysosomal phospholipid bis(monoacylglycero)phosphate is synthesized via intra- and extralysosomal pathways
9th International Symposium on Lipid and Membrane Biology; April, 18-20; Graz. 2024.
[Oral Communication]
Schooltink, L; Pirchheim, A; Breithofer, J; Grabner, G; Vujic, N; Kratky, D
Characterization of two new lysosomal lipid hydrolase candidates.
SFB Lipid Hydrolysis Retreat 2024
; Sep 30- Okt 2, 2024 ; St. Stefan ob Stainz, Austria . 2024.
[Oral Communication]
Bradić, I; Kuentzel, KB; Honeder, S; Grabner, GF; Vujić, N; Zimmermann, R; Birner-Gruenberger, R; Kratky, D
Off-target effects of the lysosomal acid lipase inhibitors Lalistat-1 and
Lalistat-2 on neutral lipid hydrolases
29. Annual Meeting of the AAS - Austrian Atherosclerosis Society; MAY 13-14, 2022; St-Gilgen, AUSTRIA. 2022.
[Poster]
Bradić, I; Kuentzel, KB; Honeder, S; Grabner, GF; Vujić, N; Zimmermann, R; BirnerGruenberger, R; Kratky, D
OFF-TARGET EFFECTS OF THE LYSOSOMAL ACID LIPASE INHIBITORS LALISTAT-1 AND LALISTAT-2 ON NEUTRAL LIPID HYDROLASES
8th International Graz Symposium on Lipid and Membrane Biology; APR 21-23, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Bradić, I; Kuentzel, KB; Honeder, S; Grabner, GF; Vujić, N; Zimmermann, R; BirnerGruenberger, R; Kratky, D
Off-target effects of the lysosomal acid lipase inhibitors Lalistat-1 and
Lalistat-2 on neutral lipid hydrolases
Doc Day 2022; FEB 10, 2022; Graz, AUSTRIA. 2022.
[Onlinepräsentation]
Dixon, ED; Nardo, AD; Claudel, T; Fuchs, C; Mlitz, V; Stojakovic, T; Scharnagl, H; Grabner, G; Zimmermann, R; Trauner, M
Chemical suppression of adipose triglyceride lipase improves non-alcoholic steatohepatitis in a diabetic and hyperlipidemic mouse model
J HEPATOL. 2022; 77: S688-S689.
[Poster]
Web of Science
Grabner, Gernot; Breinbauer, Rolf; Zimmermann, Robert
Inhibitors of human ATGL: Small molecules, chimeric proteins, and protein structures
DGF Young Investigator Meeting; Dec. 1, 2022; Düsseldorf, GERMANY. 2022.
[Oral Communication]
Grabner, Gernot; Breinbauer, Rolf; Zimmermann, Robert
Small-Molecule Inhibitors Targeting Lipolysis in Human Adipocytes
8th International Graz Symposium on Lipid and Membrane Biology; APR 21-23, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Schweiger, Martina; Heier, Christoph; Pototschnig, Isabella; Grabner, Gernot; Wolinski Heimo; Zechner, Rudolf
An immune-neuron-adipocyte axis guides catabolic adipose tissue remodeling in cancer associated cachexia
CPHBAT Meeting; MAY 30 - JUN 3, 2022; 2022.
[Poster]
Grabner Gernot; Breinbauer Rolf, Zimmermann Robert
Small Molecule Inhibitors Targeting Lipolysis in Human Adipocytes
44th Annual meeting of the ELC; SEP 6-9, 2021; Tutzing, GERMANY. 2021.
[Oral Communication]
Grabner, Gernot; Zechner, Rudolf; Breinbauer, Rolf; Zimmermann, Robert
Development of inhibitors for human Adipose Triglyceride Lipase (ATGL)
Deuel Conference on Lipids; MAR 3-6, 2020; San Diego, USA. 2020.
[Poster]
Grabner, Gernot; Schweiger, Martina; Breinbauer, Rolf; Zechner, Rudolf; Zimmermann, Robert
Development of Inhibitors for Adipose Triglyceride Lipase
Keystone Symposium; FEB 10-14, 2019; Banff, CANADA. 2019.
[Poster]
Grabner, Gernot; Zechner, Rudolf; Breinbauer, Rolf; Zimmermann, Robert
Development of Inhibitors for Adipose Triglyceride Lipase
; SEP 2, 2019; Prag, CZECH REPUBLIC. 2019.
[Keynote lecture]
Grabner, Gernot; Schweiger, Martina; Breinbauer, Rolf; Zechner, Rudolf; Zimmermann, Robert
Pharmacological inhibition of Adipose Triglyceride Lipase prevents metabolic disorders in mice
EASL - NAFLD Summit 2018; Geneve, SWITZERLAND. 2018.
[Poster]
Grabner, Gernot; Schweiger, Martina; Romauch, Matthias; Zechner, Rudolf; Breinbauer, Rolf; Zimmermann, Robert
Pharmacological inhibition of Adipose Triglyceride Lipase prevents metabolic disorders in mice
Clinical Trials in Diabetes; Berlin, GERMANY. 2017.
[Poster]
Taschler, U; Eichmann, T O; Radner, F P W; Grabner, G F; Wolinski, H; Storr, M, Lass, A; Schicho, R; Zimmermann, R;
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic µ-opioid sensitivity
AAS (Meeting of the Austrian Atherosclerosis Society); 8-9.Mai, 2015; St.Gilgen, AUSTRIA. 2015.
[Oral Communication]
Taschler, U; Eichmann, TO; Radner, FP; Grabner, GF; Wolinski, H; Storr, M; Lass, A; Marsche, G; Heinemann, A; Schicho, R; Zimmermann, R;
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptors and increased colonic opioid sensitivity.
21th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Joint Meeting with the British Pharmacological Society and the
Pharmacological Societies of Croatia, Serbia and Slovenia; 16–18 September, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]